Accordingly, we encourage the adoption of GLP-1RA plus SGLT2i combination therapy in patients with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or multiple risk factors for ASCVD (i.e., age 55 years, overweight/obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria)
It signals an underlying metabolic vulnerability that significantly increases your risk of developing type 2 diabetes later in life
To support a healthy concentration of nitric oxide, which helps endothelial cells relax and maintain blood flow, supporting proper blood pressure
It covers everything I need to know about your nutritional status, your general medical health, and your readiness for surgery
Antioxidant & Anti-Aging Effects Reduces oxidative stress and free radical damage at the cellular level
Semaglutide is injected once per week on the same day, typically Monday through Sunday depending on your preference